Nitric oxide and its relationship to thrombotic disorders

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 6, 2003, Pages 1183-1188

  Freedman, J E ^a   Loscalzo, J ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antioxidants; Cardia; Nitric oxide; Platelets; Superoxide; Thrombosis

Indexed keywords

ANTIOXIDANT; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE;

HEMOSTASIS; HUMAN; METABOLISM; PHYSIOLOGY; REVIEW; THROMBOCYTE; THROMBOSIS; VASCULAR ENDOTHELIUM;

ANTIOXIDANTS; BLOOD PLATELETS; ENDOTHELIUM, VASCULAR; HEMOSTASIS; HUMANS; NITRIC OXIDE; REACTIVE OXYGEN SPECIES; THROMBOSIS;

EID: 2142827032     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.00180.x     Document Type: Review

References (62)

1. Davies MJ, Thomas AC. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N Engl J Med 1984; 310: 1137-40.
2. SantosMT, Valles J, Marcus AJ, Safier M, Broekman J, Islam N, Ullman HL, Eiroa AM, Aznar J. Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. A new approach to platelet activation and recruitment. J Clin Invest 1991; 87: 571-80.
3. de Graaf JC, Banga JD, Moncada S, Palmer RM, de Groot PG, Sixma JJ. Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions. Circulation 1992; 85: 2284-90.
4. Radomski MW, Palmer MJ, Moncada S. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem Biophys Res Comms 1987; 148: 1482-9.
5. Stamler J, Mendelsohn ME, Amarante P, Smick D, Andon N, Davies PF, Cooke JP, Loscalzo J. N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor. Circulation Res 1989; 65: 789-95.
6. Cooke JP, Stamler J, Andon N, Davies PF, McKinley G, Loscalzo J. Flow stimulates endothelial cells to release a nitrovasodilator that is potentiated by reduced thiol. Am J Physiol 1990; 259: H804-H812.
7. Shultz PJ, Raij L. Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis. J Clin Invest 1992; 90: 1718-25.
8. Michelson AD, Benoit SE, Furman MI, Breckwoldt WL, Rohrer MJ, Barnard MR, Loscalzo J. Effects of nitric oxide/endothelium-derived relaxing factor on platelet surface glycoproteins. Am J Physiol 1996; 270: H1640-H1648.
9. Radomski M, Moncada S. Regulation of vascular homeostasis by nitric oxide. Thromb Haemost 1993; 70: 36-41.
10. Wirthumer-Hocke C, Silberbauer K, Sinzinger H. Effect on nitroglycerin and other organic nitrates on the in vitro biosynthesis of arachidonic acid-metabolites in washed human platelets. Prostaglandins Leuko Med 1984; 15: 317-23.
11. Negrescu E, Sazonova L, Baldenkov G, Mazaev AV, Tkachuk V. Relationship between the inhibition of receptor-induced increase in cytosolic free calcium concentration and the vasoldilator effects of nitrates in patients with congestive heart failure. Int J Cardiol 1990; 26: 175-84.
12. Pigazzi A, Heydrick S, Folli F, Benoit S, Michelson A, Loscalzo J. Nitric oxide inhibits thrombin receptor-activating peptide-induced phosphoinositide 3-kinase activity in human platelets. J Biol Chem 1999; 274: 14368-75.
13. Bossaller C, Habib GB, Yamamoto H, Williams C, Wells S, Henry PD. Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 50-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta. J Clin Invest 1986; 79: 170-4.
14. Loscalzo J. Nitric oxide insufficiency, platelet activation, and arterial thrombosis. Circ Res 2001; 88: 756-62.
15. Celermajar DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111-5.
16. Celermajar DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of symptomatic subjects relates to coronary risk factors and their interaction. J Am College Cardiol 1994; 24: 1468-74.
17. Yao S, Ober J, Krishnaswami A, Ferguson J, Anderson H, Golino P, Buja L, Willerson J. Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stensosed and endotheliuminjured arteries. Circulation 1992; 86: 1302-9.
18. Stagliano N, Zhao W, Prado R, Dewanjee M, Ginsberg M, Dietrich W. The effect of nitric oxide synthase inhibition on acute platelet accumulation and hemodynamic depression in a rat model of thromboembolic stroke. J Cerebral Blood Flow Metabolism 1997; 17: 1182-90.
19. Waddington S, Cook H, Reaveley D, Jansen A. Cattell V. L-arginine depletion inhibits glomerular nitric oxide synthesis and exacerbates rat nephrotoxic nephritis. Kidney International 1996; 49: 1090-6.
20. Broeders M, Tangelder G, Slaaf D, Reneman R, oude Egbrink M. Endogenous nitric oxide protects against thromboembolism in venules but not in arterioles. Arteriosclerosis Thrombosis Vascular Biol 1998; 18: 139-45.
21. Folts J, Stamler J, Loscalzo J. Intravenous nitroglycerin infusion inhibits periodic platelet thrombus formation in stenosed dog coronary arteries. Circulation 1991; 83: 2122-7.
22. Mehta JL, Chen LY, Kone BC, Mehta P, Turner P. Identification of constitutive and inducible forms of nitric oxide synthase in human platelets. J Lab Clin Med 1995; 125: 370-7.
23. Sase K, Michel T. Expression of constitutive endothelial nitric oxide synthase in human blood platelets. Life Sci 1995; 57: 2049-55.
24. Chen LY, Mehta JL. Variable effects of L-arginine analogs on Larginine-nitric oxide pathway in human neutrophils and platelets may relate to different nitric oxide synthase isoforms. J Pharmacol Exp Therapeutics 1996; 276: 253-7.
25. Simon DI, Stamler JS, Loh E, Loscalzo J, Frances SA, Creager MA. Effect of nitric oxide synthase inhibition on bleeding time in humans. J Cardiovascular Pharmacol 1995; 26: 339-42.
26. Bodzenta-Lukaszyk A, Gabryelewicz A, Lukaszyk A, Bielawiec M, Konturek JW, Domschke W. Nitric oxide synthase inhibition and platelet function. Thrombosis Res 1994; 75: 667-72.
27. Zhou Q, Hellermann G, Solomonson L. Nitric oxide release from resting human platelets. Thrombosis Res 1995; 77: 87-96.
28. Malinski T, RadomskiMW, Taha Z, Moncada S. Direct electrochemical measurement of nitric oxide released from human platelets. Biochem Biophys Res Comms 1993; 194: 960-5.
29. Radomski MW, Palmer RMJ, Moncada S. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA 1990; 87: 5193-7.
30. Freedman JE, Loscalzo J, Barnard MR, Alpert C, Keaney JF Jr, Michelson A. Nitric oxide released from activated platelets inhibits platelet recruitment. J Clin Invest 1997; 100: 350-6.
31. Freedman J, Sauter R, Battinelli B, Ault A, Knowles C, Huang P, Loscalzo J. Deficient platelet-derived nitric oxide and enhanced hemostasis in mice lacking the NOS3 gene. Circulation Res 1999; 84: 1416-21.
32. DeWood MA, Spores J, Notske R, Mouser LT, Burroughs R, Golden MS, Lang HT. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 1980; 303: 897-902.
33. Falk E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. Circulation 1985; 71: 699-708.
34. Freedman JE, Ting B, Hankin B, Loscalzo J, Keaney JFJ, Vita JA. Impaired platelet production of nitric oxide in patients with unstable angina. Circulation 1998; 98: 1481-6.
35. Langford E, Wainwright R, Martin J. Platelet activation in acute myocardial infarction and angina is inhibited by nitric oxide donors. Arterioscler Thromb Vasc Biol 1996; 16: 51-5.
36. Minamino T, Kitakaze M, Sato H, Asanuma H, Funaya H, Koretsune Y, Hori M. Plasma levels of nitrite/nitrate and platelet cGMP levels are decreased in patients with atrial fibrillation. Arterioscler Thromb Vasc Biol 1997; 17: 3191-5.
37. Noris M, Morigi M, Donadelli R, Aiell S, Foppolo M, Todeschini M, Orisio S, Remussi G, Remussi A. Nitric oxide synthesis by cultured endothelial cells is modulated by flow condition. Circulation Res 1995; 76: 536-43.
38. Clark B, Ludmir J, Epstein F, Alvarez J, Tavara L, Bazul J, Franco A, Maradiegue E, Ludmir A. Urinary cyclic GMP, endothelin, and prostaglandin E2 in normal pregnancy and preeclampsia. Am J Perinatol 1997; 14: 559-62.
39. Noris M, Ruggenenti P, Todeschini M, Figliuzzi M, Macconi D, Zoja C, Paris S, Gaspari F, Remuzzi G. Increased nitric oxide formation in recurrent thrombotic microangiopathies: a possible mediator of microvasclar injury. Am J Kidney Dis 1996; 27: 790-6.
40. O'Donnell CJ, Larson MG, Feng D, Sutherland PA, Lindpaintner K, Myers RH, D'Agostino RA, Levy D, Tofler GH. Genetic and environmental contributions to platelet aggregation: the Framingham heart study. Circulation 2001; 103: 3051-6.
41. Marsden PA, Heng HH, Scherer SW, Stewart RJ, Hall AV, Shi XM, Tsui LC, Schappert KT. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem 1993; 268: 17478-88.
42. Wang XL, Mahaney MC, Sim AS, Wang J, Blangero J, Almasy L, Badenhop RB, Wilcken DE. Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler Thromb Vasc Biol 1997; 17: 3147-53.
43. Yoon Y, Song J, Hong SH, Kim JQ. Plasma nitric oxide concentrations and nitric oxide synthase gene polymorphisms in coronary artery disease. Clin Chem 2000; 46: 1626-30.
44. Lacolley P, Gautier S, Poirier O, Pannier B, Cambien F, Benetos A. Nitric oxide synthase gene polymorphisms, blood pressure and aortic stiffness in normotensive and hypertensive subjects. J Hypertens 1998; 16: 31-5.
45. Shimasaki Y, Yasue H, Yoshimura M, Nakayama M, Kugiyama K, Ogawa H, Harada E, Masuda T, Koyama W, Saito Y, Miyamoto Y, Ogawa Y, Nakao K. Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. J Am Coll Cardiol 1998; 31: 1506-10.
46. Elbaz A, Poirier O, Moulin T, Chedru F, Cambien F, Amarenco P. Association between the Glu298Asp polymorphism in the endothelial constitutive nitric oxide synthase gene and brain infarction. The GENIC Investigators. Stroke 2000; 31: 1634-9.
47. Hingorani AD, Liang CF, Fatibene J, Lyon A, Monteith S, Parsons A, Haydock S, Hopper RV, Stephens NG, O'Shaughnessy KM, Brown MJ. A common variant of the endothelial nitric oxide synthase (Glu298!Asp) is a major risk factor for coronary artery disease in the UK. Circulation 1999; 100: 1515-20.
48. Wang XL, Sim AS, Badenhop RF, McCredie RM, Wilcken DE. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat Med 1996; 2: 41-5.
49. Tanus-Santos JE, Desai M, Deak LR, Pezzullo JC, Abernethy DR, Flockhart DA, Freedman JE. Effects of endothelial nitric oxide synthase gene polymorphisms on platelet function, nitric oxide release, and interactions with estradiol. Pharmacogenetics 2002; 12: 407-13.
50. Bressler N, Broekman M, Marcus A. Concurrent studies of oxygen consumption and aggregation in stimulated human platelets. Blood 1979; 53: 167-78.
51. Burch J, Burch P. Glutathione disulfide production during arachidonic acid oxygenation in human platelets. Prostaglandins 1990; 39: 123-4.
52. Handin R, Karabin R, Boxer G. Enhancement of platelet aggregation by superoxide anion. J Clin Invest 1987; 59: 959-6.
53. Calzada C, Vericei E, Lagarde M. Decrease in platelet reduced glutathione increases lipoxygenase activity and decreases vitamin E. Lipids 1991; 26: 696-9.
54. Meng Y, Trachtenburg J, Ryan U, Abendschein D. Potentiation of endogenous nitric oxide with superoxide dismutase inhibits plateletmediated thrombosis in injured stenotic arteries. J Am College Cardiol 1995; 25: 269-75.
55. Ikeda H, Koga Y, Oda T, Kuwano K, Nakayama H, Ueno T, Toshima H, Michael L, Entman M. Free oxygen radicals contribute to platelet aggregation and cyclic flow variations in stenosed and endotheliuminjured canine coronary arteries. J Am College Cardiol 1994; 24: 1749- 56.
56. Freedman JE, Frei B, Welch GN, Loscalzo J. Glutathione peroxidase potentiates the inhibition of platelet function by S-nitrosothiols. J Clin Invest 1995; 96: 394-400.
57. Freedman JE, Loscalzo J, Benoit SE, Valeri CR, Barnard MR, Michelson AD. Decreased platelet inhibition by nitric oxide in two brothers with a history of arterial thrombosis. J Clin Invest 1996; 97: 979-87.
58. Inbal A, Kenet G, Freedman J, Michelson A, Loscalzo J. Impaired NOmediated inhibition of platelet aggregation and P-selectin expression by plasma from patients with childhood stroke. Thromb Haemost 1997; (Suppl.): 304.
59. Keaney J, Stamler JJ, Folts J, Loscalzo J. NO forms a stable adduct with serum albumin that has potent antiplatelet properties in vivo. Clin Res 1992; 40: 194A.
60. Rimm E, Stampfer M, Ascherio A, Giovannucci E, Colditz G,WilletW. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993; 328: 1444-9.
61. Freedman J, Li L, Vita J, Keaney J. Alpha-tocopherol levels are associated with platelet release of nitric oxide. J Am College Cardiol 1999; 33: 264a.
62. Freedman JE, Farhat J, Loscalzo J, Keaney JF Jr. Alpha-tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism. Circulation 1996; 94: 2434-40.